Evidence map›Paper›PMID 42341012›Full record

ArticlePloS one2026

Mitochondrial dysfunction and autophagy activation underlie NK cell impairment induced by Cannabis.

Andrée-Ann Bolduc, Tony Tremblay, Mikhlid H Almutairi, Abdelhabib Semlali, Lionel Loubaki

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrée-Ann BolducHéma-Québec, Medical Affairs and Innovation, Québec, Québec, Canada.
Tony TremblayHéma-Québec, Medical Affairs and Innovation, Québec, Québec, Canada.
Mikhlid H AlmutairiDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Abdelhabib SemlaliGroupe de Recherche en Écologie Buccale, Faculté de Médecine Dentaire, Université Laval, Québec, Québec, Canada.
Lionel LoubakiHéma-Québec, Medical Affairs and Innovation, Québec, Québec, Canada.ORCID https://orcid.org/0000-0002-4744-5387

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cannabis use continues to rise in Canada, prompting concerns due to its potential impact on immune function. This study investigated the effect of a cannabis joint extract (CJE) on natural killer (NK) cells and explored the mechanisms underlying its potential anti-inflammatory properties. Peripheral blood mononuclear cells (PBMCs) were exposed to varying concentrations of CJE to assess cytotoxicity. Flow cytometry was employed to evaluate oxidative stress, autophagy, mitochondrial membrane potential, caspase-3 activation, and DNA damage. Additionally, NK cell cytotoxicity, migration, and adhesion were analyzed. Data indicated that CJE exposure led to dose-dependent cytotoxicity in NK cells, primarily through apoptosis. Specifically, at a concentration of 3 μg/mL, CJE significantly increased reactive oxygen species (ROS), autophagy markers, caspase activation, and DNA damage, while reducing mitochondrial membrane potential. Moreover, CJE impaired NK cell-mediated killing of HeLa cells, though their migratory and adhesive abilities were unaffected. These findings evidence that cannabis can detrimentally affect NK cell viability and function via mechanisms involving autophagy and caspase-dependent apoptosis.

Indexed as

AutophagyCannabisKiller Cells, NaturalMitochondriaPlant ExtractsApoptosisCaspase 3Cell AdhesionCell MovementCell SurvivalDNA DamageHeLa CellsHumansLeukocytes, MononuclearMembrane Potential, MitochondrialOxidative StressCaspase 3Plant ExtractsReactive Oxygen Species

Identifiers

PMID42341012
PMCPMC13293387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.